PLC Medical Systems gets expedited review for Heart Laser:
This article was originally published in Clinica
The US FDA has granted expedited review status to PLC Medical Systems for its PMA application for transmyocardial revascularisation using the Heart Laser. The device will be given priority review because no marketed alternative is available for cardiac patients with medically refractory angina who are not candidates for angioplasty or bypass surgery.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.